Loading...
•
Dec 31, 2025
Huron Q4 2025 Earnings Report
Huron Q4 2025 Earnings Report
Key Takeaways
Huron delivered strong fourth-quarter results with an 11.3% increase in revenues before reimbursable expenses, driven by record performance in the healthcare and commercial segments. While GAAP net income and EPS saw a slight decline due to contingent consideration charges, adjusted EBITDA and adjusted EPS grew significantly, reflecting continued margin expansion and operational efficiency.
Revenues before reimbursable expenses grew 11.3% to $432.3 million in Q4 2025.
Adjusted EBITDA increased 19.7% to $68.0 million, representing a margin of 15.7%.
Adjusted diluted EPS rose 14.2% to $2.17, compared to $1.90 in the prior year quarter.
The company authorized an increase in its share repurchase program from $700 million to $900 million.
Revenue by Segment
Forward Guidance
Huron provided full year 2026 guidance reflecting continued growth and margin expansion expectations.
Positive Outlook
- Full year 2026 revenue expected in a range of $1.78 billion to $1.86 billion.
- Adjusted EBITDA margin projected between 14.5% and 15.0%.
- Adjusted diluted EPS guidance range of $8.35 to $9.15.
- Increased share repurchase authorization to $900 million.
- Continued demand for AI and advanced technology expertise.
Challenges Ahead
- Ongoing market pressures facing clients in primary end markets.
- Unfavorable impact of contingent consideration remeasurement charges.
- Slight decline in GAAP net income compared to the prior year quarter.
- Decrease in demand for Digital capability within the Healthcare segment.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...